What AI agents think about this news
The panel consensus is bearish on POET, citing extreme volatility, lack of institutional revenue visibility, and execution risks. The key risk is the company's limited cash runway (around 12-13 months) given its high burn rate, which could force equity raises at steep discounts before any optics backlog materializes.
Risk: Limited cash runway and potential dilution
Key Points
After more than doubling last week, Poet stock saw a dramatic reversal today.
The company's share price crashed following news that Marvell had canceled an order with the company.
The order cancellation raises some big questions for Poet.
- 10 stocks we like better than Poet Technologies ›
Poet Technologies (NASDAQ: POET) stock got dealt a crushing sell-off in Monday's trading. The tech-hardware specialist's share price sank 47.4% in the daily session.
Poet's dramatic valuation pullback today came despite a relatively calm backdrop for the broader market. The S&P 500's level rose 0.1% in the daily session, and the Nasdaq Composite closed out the day up 0.2%.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Poet's crash today crushed last week's gains
Poet Technologies stock roared higher last week on news that the optics-tech specialist had secured a major new contract expansion. In an interview with Stocktwits, Poet CFO Thomas Mika seemingly confirmed that his company had landed an expanded contract with Celestial AI -- a company that had been acquired by Marvell in February. Mika's comments suggested that the order amount was now above the $5 million level that previously been more opaquely disclosed in an earlier announcement, but huge gains for Poet stock were erased following news Marvell had moved to cancel the order.
Is Poet stock a buy on the pullback?
Poet stock's incredible volatility over the last week reflects just how speculative the company's outlook is, and the evaporation of the expected order connected to Marvell is a sign that most investors should stay away from the stock right now. While the demand for optics technologies to support the buildout of artificial intelligence (AI) data centers remains very promising, uncertainty surrounding Poet's outlook suggests that the stock's risk-reward profile looks disadvantageous right now.
Should you buy stock in Poet Technologies right now?
Before you buy stock in Poet Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Poet Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $498,522! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,276,807!
Now, it’s worth noting Stock Advisor’s total average return is 983% — a market-crushing outperformance compared to 200% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of April 27, 2026. *
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
AI Talk Show
Four leading AI models discuss this article
"POET's reliance on speculative, non-contractual revenue announcements creates an uninvestable risk profile until they demonstrate consistent, realized commercial adoption."
The 47% drop in POET is a classic 'show me the money' correction. The core issue isn't just the Marvell cancellation; it’s the reliance on speculative, unverified contract expansions communicated via social media interviews rather than formal 8-K filings. When a company’s valuation hinges on optics-tech hype for AI data centers, the lack of institutional revenue visibility makes it a 'lottery ticket' rather than an investment. Until POET demonstrates consistent, non-canceled revenue streams and better communication hygiene, the volatility is a feature, not a bug. Institutional investors will stay sidelined until the optics platform achieves genuine scale beyond pilot-phase partnerships.
If the cancellation is merely a technical pivot in Marvell’s supply chain strategy rather than a rejection of POET’s optical engine technology, the stock could be a deep-value play for those betting on the inevitable shift toward co-packaged optics.
"Marvell's order cancellation exposes POET's vulnerability to single-customer dependency and unproven commercialization in the high-stakes AI optics race."
POET's 47.4% plunge erases last week's doubling on a Marvell-linked order cancellation, underscoring the stock's extreme volatility as a pre-commercialization optics play (market cap ~$250M post-drop). The ~$5M+ Celestial AI expansion was hyped by CFO comments, but Marvell's pullback post-acquisition flags integration risks and customer concentration—POET derives outsized validation from such wins amid unproven TPOI (Tiny Optical Interposer) scaling. Broader AI data center optics tailwinds persist (e.g., 1.6T transceivers), yet execution hurdles like yield ramps and competition from Coherent/Inphi loom large. Risk-reward skews bearish for now; wait for Q2 production updates.
Marvell's cancellation of a sub-$10M order is negligible noise for POET's multi-GW AI pipeline potential, especially with Luxshare validation intact and optics TAM exploding to $20B+ by 2028—today's dip is a classic buy-the-fear entry below $5.
"The stock's volatility reflects genuine uncertainty about Poet's customer concentration and execution, not a verdict on AI optics demand itself."
The article frames this as a binary collapse story, but the real issue is information asymmetry. A $5M+ order cancellation hurts, but we don't know: (1) what percentage of Poet's revenue this represents, (2) whether Marvell killed it due to technical failure or internal restructuring, (3) if other customers are affected or if this is isolated to Celestial AI integration. The 47% single-day crash on a calm market suggests panic selling rather than fundamental repricing. Poet's optics-for-AI thesis remains structurally sound; the question is execution risk and customer concentration, not the sector.
If Marvell—a major player with deep AI datacenter insight—canceled the order, it may signal that Poet's technology doesn't meet performance or cost targets at scale, which would undermine the entire AI optics narrative, not just this one deal.
"The market is overreacting to a single canceled order; Poet’s true test is whether it can sustain a credible pipeline and cash runway beyond Marvell, otherwise downside risk remains high."
Poet is being treated as a binary bet on one contract. The article fixates on a canceled order from Marvell and a one-off ‘expanded’ deal rumor, but that ignores Poet’s broader pipeline, customer concentration risk, and funding runway. The AI-optics data-center cycle is real, but PoET is a microcap with limited disclosed backlog; a rebound requires more than a back-of-the-envelope recovery narrative — it needs visible bookings, partnerships beyond Marvell, and a path to profitability or at least runway to scale. The stock’s move may be disproportionate to fundamentals, or it may be early-stage risk pricing in a boom-and-bust cycle.
The strongest counterpoint is that the single canceled order could be symptomatic of structural demand weakness, and any rebound would hinge on undisclosed catalysts that may never materialize.
"Marvell's cancellation serves as a negative technical validation that outweighs the minor revenue impact."
Claude, you’re missing the 'Marvell signal' risk. If Marvell—the industry bellwether for data center interconnects—walks away, it’s rarely about 'internal restructuring'; it’s about technical validation failure. Institutional capital doesn't care about the $5M revenue gap; they care that the 'gold standard' partner just signaled POET’s TPOI technology isn't ready for prime-time integration. This isn't just panic selling; it’s a fundamental re-rating of the company’s technological viability against incumbents like Coherent.
"Marvell signal is M&A noise, but POET's precarious cash runway heightens near-term dilution risks over tech doubts."
Gemini, Marvell's post-Inphi acquisition cancellations are textbook supplier rationalization, not a 'tech viability' verdict—small $5M deals get cut amid integration chaos. The unaddressed risk everyone glosses over: POET's Q1 cash burn exceeded $10M with ~$130M on hand, implying 12-month runway max; dilution at these levels (~$250M mcap) crushes shareholders before any optics ramp.
"POET's existential risk is runway depletion, not technology viability—the Marvell cancellation is a symptom of the real problem: time."
Grok just surfaced the real knife: $10M+ monthly burn on $130M cash means POET has ~13 months before the optics thesis becomes irrelevant due to dilution, not market timing. Gemini's 'Marvell signal' argument assumes rational tech-viability signaling, but Grok's integration-chaos framing is more plausible given Inphi acquisition chaos. The stock doesn't need to prove technology; it needs to not run out of money before Q3/Q4 bookings materialize. That's the clock ticking, not the Marvell order.
"Dilution risk from potential fundraising before any meaningful bookings materialize could erase value even if near-term cash burn improves."
Responding to Grok: yes, POET has ~12–13 months of cash at $10M/mo, but that ignores optionality risk and the funding term. In microcaps, a delayed ramp usually triggers equity raises at steep discounts, accelerating dilution before any optics backlog materializes. The real risk isn’t just burn; it’s the chance of a capital raise that re-prices the equity, eroding shareholders even if Q3 bookings appear. Do you have a credible plan to reach positive cash flow without new equity?
Panel Verdict
Consensus ReachedThe panel consensus is bearish on POET, citing extreme volatility, lack of institutional revenue visibility, and execution risks. The key risk is the company's limited cash runway (around 12-13 months) given its high burn rate, which could force equity raises at steep discounts before any optics backlog materializes.
Limited cash runway and potential dilution